Evolent Health, Inc (EVH) financial statements (2022 and earlier)

Company profile

Business Address 800 NORTH GLEBE RD, SUITE 500
ARLINGTON, VA 22203
State of Incorp. DE
Fiscal Year End December 31
SIC 8741 - Management Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments266344103228238179155
Cash and cash equivalents266340101228238135146
Short-term investments 42  449
Restricted cash and investments76142015562345
Receivables1291227278755120
Contract with customer, asset 022✕✕✕
Other undisclosed current assets53653224314
Total current assets:524546229488378265184
Noncurrent Assets
Operating lease, right-of-use asset505872✕✕✕✕
Property, plant and equipment81868574513113
Long-term investments and receivables1022140132245
Long-term investments51713962245
Accounts and financing receivable, after allowance for credit loss5517   
Intangible assets, net (including goodwill)7066238811,103869885772
Goodwill426355572768628627609
Intangible assets, net (excluding goodwill)280268308335241259163
Contract with customer, asset, net  11✕✕✕
Capitalized contract cost, net33273619✕✕✕
Restricted cash and investments13786362
Other undisclosed noncurrent assets214618910 
Total noncurrent assets:8958241,2691,234935935831
TOTAL ASSETS:1,4191,3701,4981,7221,3131,2001,016
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities25516510622110811145
Accounts payable963237147434417
Accrued liabilities10785334930296
Employee-related liabilities52483525353822
Deferred revenue121420✕✕✕✕
Debt 276    
Due to related parties   1   
Deferred revenue and credits✕✕✕✕252015
Contract with customer, liability✕✕✕21✕✕✕
Other undisclosed current liabilities1781966127   
Total current liabilities:44540219326913313260
Noncurrent Liabilities
Long-term debt and lease obligation27332669    
Long-term debt, excluding current maturities216263     
Operating lease, liability586369✕✕✕✕
Liabilities, other than long-term debt7231519123621
Deferred revenue  1✕✕✕✕
Contract with customer, liability✕✕✕2✕✕✕
Deferred tax liabilities, net✕✕✕ 22121
Deferred income tax liabilities112✕✕✕✕
Other liabilities622121710150
Other undisclosed noncurrent liabilities  292245121120 
Total noncurrent liabilities:28034937626413415621
Total liabilities:72675156953326628881
Stockholders' equity
Stockholders' equity attributable to parent, including:6946209221,1441,011703649
Common stock1      
Treasury stock, value(21)(21)     
Additional paid in capital1,3411,2291,1741,093924555342
Accumulated other comprehensive loss(0)(0)(0)(0)   
Retained earnings (accumulated deficit)(627)(589)(252)5086147307
Other undisclosed stockholders' equity attributable to parent 111111
Stockholders' equity attributable to noncontrolling interest  74635210285
Total stockholders' equity:6946209291,1891,046912935
TOTAL LIABILITIES AND EQUITY:1,4191,3701,4981,7221,3131,2001,016

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues9081,02284662743525497
Revenue, net✕✕✕✕43525497
Cost of revenue
(Policyholder Benefits and Claims Incurred, Net)		(20)  (1)   
Gross profit:8871,02284662643525497
Operating expenses(950)(1,293)(1,153)(675)(508)(492)(140)
Other undisclosed operating income20  1   
Operating loss:(42)(271)(307)(47)(73)(237)(43)
Nonoperating income03342 414
Investment income, nonoperating03432 414
Other nonoperating income (expense)(0)(0)(0)0   
Interest and debt expense(25)(33)(15)(5)(4)  
Income (loss) from continuing operations before equity method investments, income taxes:(68)(301)(318)(49)(75)(237)371
Income (loss) from equity method investments1310(9)(5)(2)(1)(28)
Other undisclosed income (loss) from continuing operations before income taxes25(47)  010
Income (loss) from continuing operations before income taxes:(30)(338)(327)(54)(76)(238)343
Income tax expense (benefit)(0)422(0)711(23)
Income (loss) from continuing operations:(30)(334)(306)(54)(70)(227)320
Loss from discontinued operations(7)      
Net income (loss):(38)(334)(306)(54)(70)(227)320
Net income attributable to noncontrolling interest  4296713
Net income (loss) attributable to parent:(38)(334)(302)(53)(61)(160)332
Preferred stock dividends and other adjustments      (2)
Net income (loss) available to common stockholders, basic:(38)(334)(302)(53)(61)(160)330
Convertible preferred dividends      2
Other undisclosed net loss available to common stockholders, diluted      (13)
Net income (loss) available to common stockholders, diluted:(38)(334)(302)(53)(61)(160)320

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(38)(334)(306)(54)(70)(227)320
Other undisclosed comprehensive loss(0)(0)(0)(0)   
Comprehensive income (loss):(38)(334)(306)(54)(70)(227)320
Comprehensive income, net of tax, attributable to noncontrolling interest  4296713
Comprehensive income (loss), net of tax, attributable to parent:(38)(334)(302)(53)(61)(160)332

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: